Opaleye Management Inc.
Filing Date
Global Rank
#2,155
/ 7,976
▲ 387
Top Industry
Biotechnology
47.2%
3Y Alpha vs SPY
+14.0%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+146.0%
SPY
+76.5%
Annualised alpha
+14.1%
Max drawdown
−42.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
42 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
26.7%
+1.3 pts
Top 5
55.9%
+1.3 pts
Top 10
73.3%
−4.2 pts
HHI
1,038
Diversified+26
Portfolio Trend
23 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $704,144,428 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| DERM | Journey Medical Corp | +876,064 | 971,064 | $6,913,975 | |
| CDXS | Codexis, Inc. | +195,000 | 12,795,000 | $31,219,800 | |
| CGON | CG Oncology, Inc. | +144,000 | 410,000 | $16,514,800 | |
| LQDA | Liquidia Corp | +140,000 | 2,615,000 | $59,465,100 | |
| STOK | Stoke Therapeutics, Inc. | +119,897 | 682,017 | $16,027,399 | |
| SRPT | Sarepta Therapeutics, Inc. | +85,000 | 585,000 | $11,272,950 | |
| MBX | MBX Biosciences, Inc. | +13,681 | 253,000 | $4,427,500 | |
| EWTX | Edgewise Therapeutics, Inc. | +10,000 | 500,000 | $8,110,000 | |
| IRON | Disc Medicine, Inc. | +7,355 | 193,773 | $12,804,519 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | −1,607,750 | 316,550 | $477,990 | |
| GOSS | Gossamer Bio, Inc. | −820,000 | 2,725,000 | $7,166,750 | |
| ARVN | Arvinas, Inc. | −692,182 | 987,818 | $8,416,209 | |
| LRMR | Larimar Therapeutics, Inc. | −389,133 | 3,720,867 | $12,018,400 | |
| IMNM | Immunome Inc. | −344,581 | 3,185,000 | $37,296,350 | |
| PEPG | PepGen Inc. | −165,000 | 75,000 | $346,500 | |
| IRD | Opus Genetics, Inc. | −120,000 | 1,100,000 | $1,815,000 | |
| ZYME | Zymeworks Inc. | −110,000 | 100,000 | $1,708,000 | |
| ALMS | Alumis Inc. | −110,000 | 665,000 | $2,653,350 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −13,300 | 461,700 | $46,627,083 | |
| RVMD | Revolution Medicines, Inc. | −5,000 | 100,000 | $4,670,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | 363,257 | $14,432,200 | |
| ALKS | Alkermes plc. | 450,000 | $13,500,000 | |
| ANNX | Annexon, Inc. | 2,600,000 | $7,930,000 | |
| SLGL | Sol-Gel Technologies Ltd. | 204,835 | $5,970,940 | |
| PLX | Protalix BioTherapeutics, Inc. | 2,580,556 | $5,728,834 | |
| TMCI | Treace Medical Concepts, Inc. | 702,245 | $4,712,063 | |
| ADCT | ADC Therapeutics SA | 682,529 | $2,730,116 | |
| CABA | Cabaletta Bio, Inc. | 808,882 | $1,892,783 | |
| SYRE | Spyre Therapeutics, Inc. | 65,000 | $1,089,400 | |
| RIGL | Rigel Pharmaceuticals Inc | 37,787 | $1,070,505 | |
| ACOG | Alpha Cognition Inc. | 115,142 | $749,574 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
4 positions
42 positions ·
$704,144,428 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ADGM |
Adagio Medical Holdings, Inc.
Healthcare
|
Held | 110,571 | $214,507 | 0.03% | |
| IBIO |
iBio, Inc.
Healthcare
|
Held | 375,000 | $311,250 | 0.04% | |
| PEPG |
PepGen Inc.
Healthcare
|
Reduced | 75,000 | $346,500 | 0.05% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 316,550 | $477,990 | 0.07% | |
| ACOG |
Alpha Cognition Inc.
Healthcare
|
NEW | 115,142 | $749,574 | 0.11% | |
| RIGL |
Rigel Pharmaceuticals Inc
Healthcare
|
NEW | 37,787 | $1,070,505 | 0.15% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 65,000 | $1,089,400 | 0.15% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Reduced | 100,000 | $1,708,000 | 0.24% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
Reduced | 1,100,000 | $1,815,000 | 0.26% | |
| CABA |
Cabaletta Bio, Inc.
Healthcare
|
NEW | 808,882 | $1,892,783 | 0.27% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 665,000 | $2,653,350 | 0.38% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
NEW | 682,529 | $2,730,116 | 0.39% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 390,000 | $3,568,500 | 0.51% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 253,000 | $4,427,500 | 0.63% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 100,000 | $4,670,000 | 0.66% | |
| TMCI |
Treace Medical Concepts, Inc.
Healthcare
|
NEW | 702,245 | $4,712,063 | 0.67% | |
| PLX |
Protalix BioTherapeutics, Inc.
Healthcare
|
NEW | 2,580,556 | $5,728,834 | 0.81% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
NEW | 204,835 | $5,970,940 | 0.85% | |
| DERM |
Journey Medical Corp
Healthcare
|
Added | 971,064 | $6,913,975 | 0.98% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 105,000 | $6,975,150 | 0.99% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Reduced | 2,725,000 | $7,166,750 | 1.02% | |
| ANNX |
Annexon, Inc.
Healthcare
|
NEW | 2,600,000 | $7,930,000 | 1.13% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 500,000 | $8,110,000 | 1.15% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Reduced | 987,818 | $8,416,209 | 1.20% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 903,442 | $8,492,354 | 1.21% | |
| XOMA |
XOMA Royalty Corp
Healthcare
|
Held | 255,087 | $9,831,052 | 1.40% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 585,000 | $11,272,950 | 1.60% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Reduced | 3,720,867 | $12,018,400 | 1.71% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 193,773 | $12,804,519 | 1.82% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 450,000 | $13,500,000 | 1.92% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 363,257 | $14,432,200 | 2.05% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 682,017 | $16,027,399 | 2.28% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Added | 410,000 | $16,514,800 | 2.35% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Held | 1,595,000 | $18,645,550 | 2.65% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Held | 535,000 | $19,326,875 | 2.74% | |
| CDXS |
Codexis, Inc.
Healthcare
|
Added | 12,795,000 | $31,219,800 | 4.43% | |
| SNWV |
SANUWAVE Health, Inc.
Healthcare
|
Held | 980,000 | $36,730,400 | 5.22% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 3,185,000 | $37,296,350 | 5.30% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 461,700 | $46,627,083 | 6.62% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 2,615,000 | $59,465,100 | 8.45% | |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
Held | 2,860,000 | $62,147,800 | 8.83% | |
| HROW |
Harrow, Inc.
Healthcare
|
Held | 3,905,000 | $188,142,900 | 26.72% |